VAERS reports by lot

Merck Pneumococcal lot R022249: VAERS reports

33 VAERS reports list lot R022249 as a Merck Pneumococcal vaccine, received between 2018-10-14 and 2022-12-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
6%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4543%
General / Systemic (non-local)1413%
Musculoskeletal1111%
Dermatological (non-injection-site)1111%
Cardiac / Cardiovascular88%
Allergic / Anaphylactic88%
Respiratory44%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Illinois3
Texas3
Washington2
Missouri2
New York2
Indiana2
Michigan2
Kansas1
Massachusetts1
Mississippi1
Tennessee1

Reports by month received

2018-102
2018-116
2018-125
2019-014
2019-022
2019-032
2019-041
2019-052
2019-061
2019-081
2019-092
2019-102
2019-111
2020-081
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.